| lobaplatin (D19466) / AEterna Zentaris |
ChiCTR-ONC-12002060: The effectiveness fety of neoadjuvant chemotherapy of lobaplatin combined with 5-FU, concurrent chemotherapy of lobaplatin IMRT in local-regionally advanced nasopharyngeal carcinoma : a prospective, non-controlled clinical trial |
|
|
| Completed | 2 | 59 | | Neoadjuvant chemotherapy of lobaplatin combined with 5-FU, concurrent chemotherapy of lobaplatin and IMRT | Nasopharyngeal Carcinoma Department of Sun Yat-sen University Cancer Center; Nasopharyngeal Carcinoma Department of Sun Yat-sen University Cancer Center, Self-financing | Nasopharyngeal Carcinoma | | | | |
ChiCTR-OIC-17011436: A phase II-III clinical study of the joint Lobaplatin and radiotherapy for esophageal cancer in elderly patients |
|
|
| Not yet recruiting | 2 | 69 | | radioplatin joint radiotherapy | Radiotherapy department of the First People's Hospital of Huai'an City; First People's Hospital of Huai'an City, Self-financing | esophageal cancer | | | | |
ChiCTR2000033338: Immunotherapy combined with Albumin-bound paclitaxel and lobaplatin-induced chemotherapy in the treatment of locally advanced esophageal cancer |
|
|
| Not yet recruiting | 2 | 34 | | Immunotherapy combined with Albumin-bound paclitaxel and lobaplatin-induced chemotherapy | The First Medical Center of PLA General Hospital; The First Medical Center of PLA General Hospital, Self-financing | Esophageal cancer | | | | |
WUHIPEC01, NCT04808466: Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy |
|
|
| Recruiting | 2 | 231 | RoW | Paclitaxel, Lobaplatin | Wuhan Union Hospital, China | Gastric Cancer, Chemotherapy Effect, Surgery, Metastasis, Survival | 09/22 | 09/25 | | |
ChiCTR1900025080: Albumin-bound paclitaxel combined with lobaplatin-induced chemotherapy + albumin-bound paclitaxel combined with lobaplatin in the treatment of locally advanced esophageal cancer |
|
|
| Not yet recruiting | 2 | 34 | | Induction chemotherapy followed by concurrent chemoradiotherapy | Chinese PLA General Hospital; Chinese PLA General Hospital, Shiyao Group Ouyi Pharmaceutical Co., Ltd. | Esophageal cancer | | | | |
NCT05546255: Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer |
|
|
| Recruiting | 2 | 40 | RoW | Eribulin Mesylate, Lobaplatin | Chinese Academy of Medical Sciences | Triple Negative Breast Cancer | 12/22 | 12/23 | | |
NCT06170697: Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 46 | RoW | Camrelizumab, immunotherapy, Cisplatin, chemotherapy, Carboplatin, Lobaplatin, Nedaplatin, Radiotherapy, radiation therapy | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Head and Neck Squamous Cell Carcinoma | 07/24 | 07/25 | | |
WUHIPEC02, NCT04845490: Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy |
|
|
| Not yet recruiting | 2 | 201 | NA | Mitomycin, Lobaplatin | Wuhan Union Hospital, China | Colorectal Cancer, Chemotherapy Effect, Surgery, Metastasis, Survival | 09/23 | 09/26 | | |
NCT06198465: Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma |
|
|
| Not yet recruiting | 2 | 24 | RoW | adebrelimab,Paclitaxel,Lobaplatin,Fluorouracil | Xijing Hospital | Adebrelimab, Esophageal Cancer, Perioperative Period | 12/24 | 12/25 | | |
ChiCTR1800018249: Efficacy and Safety of Intensity-modulated radiotherapy combined with lobaplatin chemotherapy for early cervical cancer postoperative patients |
|
|
| Recruiting | 1/2 | 252 | | IMRT+Lobaplatin chemotherapy ;IMRT+Cisplatin chemotherapy | The Affiliated Hospital of Southwest Medical University; The Affiliated Hospital of Southwest Medical University, horizontal project | Cervical cancer | | | | |
